Equity (Details) - USD ($) $ / shares in Units, $ in Thousands |
1 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|
Dec. 30, 2020 |
Dec. 31, 2022 |
Dec. 31, 2021 |
Sep. 08, 2021 |
Apr. 30, 2021 |
|
| Equity (Details) [Line Items] | |||||
| Converted into shares of common stock | 25,000 | ||||
| Sale of preferred stock units (in Dollars) | $ 10 | ||||
| Aggregate gross proceeds (in Dollars) | $ 1,350 | ||||
| Price per share (in Dollars per share) | $ 1 | ||||
| Redemption payments percentage | 12.50% | ||||
| Redemption payments total (in Dollars) | $ 137 | ||||
| Common stock, shares outstanding | 113,204,002 | 113,094,002 | |||
| Weighted average market price of common stock exceed (in Dollars per share) | $ 1 | ||||
| Shares of Common stock | 25,000 | ||||
| Common Stock [Member] | |||||
| Equity (Details) [Line Items] | |||||
| Equity, description | ●Acquisition of Certain Assets of Halcyon – In January 2021, the Company issued 6,250,000 shares of common stock valued at $2.5 million ($0.40 per share; restricted from trading for a period of up to one year) in the acquisition. ●2021 First Quarter Issuances of Common Stock Units – In the first quarter of 2021, the Company issued 800,000 common stock units for total proceeds of $400,000. Each common stock unit consisted of one share of common stock and a warrant for the purchase of two shares of common stock for $0.50 each. Each warrant is exercisable any time before its expiration on the second anniversary of its issuance. The Company allocated the total proceeds based on the relative fair values of the common stock and warrants. The fair value of the warrants was determined using an options valuation model with key assumptions including a risk-free interest rate of 0.11% and historical volatility of 272%. A total of $263 thousand was allocated to the warrants and reported in additional paid-in capital. ●Warrant Exercises – In the first quarter of 2021, the Company received approximately $3 million for the exercise of 8,428,976 outstanding warrants. In the fourth quarter of 2021, the Company received $375 thousand for the exercise of 1,065,340 outstanding warrants. ●Issuances for Exchange or Conversion of Debt – The Company issued a total of 1,618,660 common shares for the exchange or conversion of outstanding indebtedness totaling $2.2 million in the first quarter of 2021. ●Issuance to Vendor for Services – In the third quarter of 2021, the Company issued 125,000 common shares valued at $117.5 thousand to a vendor for services performed. ●Issuance for Extension of Secured Note – The Company issued 20,000 common shares valued at $18 thousand as consideration to extend the maturity of a senior note in the third quarter of 2021. ●Issuance for Conversion of Series A Preferred Stock – As noted above, in the third quarter of 2021, the Company issued 75,947,376 common shares for the conversion of all outstanding shares of its Series A Preferred Stock. ●2021 Fourth Quarter Issuances of Common Stock Units – In the fourth quarter of 2021, the Company issued 958,333 common stock units to accredited investors for total proceeds of $575 thousand. Each common stock unit consists of one share of common stock and a warrant for the purchase of one share of common stock for $0.60 each. Each warrant is exercisable any time before its expiration on the second anniversary of its issuance. The Company allocated the total proceeds based on the relative fair values of the common stock and warrants. The fair value of the warrants was determined using an options valuation model with key assumptions including risk-free interest rates ranging from 0.48% to 0.70% and historical volatility ranging from 237% to 258%. A total of $277 thousand was allocated to the warrants and reported in additional paid-in capital.. ●Issuance for Extensions of Secured Note – The Company issued 110,000 common shares valued at $52.6 thousand as consideration for extensions of the maturity of a senior note in 2022. Refer to Note 5. | ||||
| Aggregate gross proceeds (in Dollars) | $ 5,000 | ||||
| Price per share (in Dollars per share) | $ 1 | ||||
| Warrant [Member] | |||||
| Equity (Details) [Line Items] | |||||
| Warrant per share (in Dollars per share) | $ 0.0001 | ||||
| Series A Preferred Stock [Member] | |||||
| Equity (Details) [Line Items] | |||||
| Shares of preferred stock | 6,328,948 | ||||
| Converted into shares of common stock | 75,947,376 | ||||
| Converting into shares of restricted common stock | 12 | ||||
| Series B Preferred Stock [Member] | |||||
| Equity (Details) [Line Items] | |||||
| Converted into shares of common stock | 25,000 | ||||
| Equity, description | On December 30, 2020, the Company sold to certain accredited investors, including Gary C. Evans, our Chief Executive Officer, an aggregate of 135 preferred stock units comprised of (i) one share of Series B Redeemable Convertible Preferred Stock, no par value, and (ii) one warrant exercisable for 50 thousand shares of common stock of the Company until December 30, 2022 at an exercise price of $0.352 per share. | ||||
| Dividends percentage | 6.00% | ||||
| Stated value per share (in Dollars) | $ 10 |